Clarithromycin
- Product NDC
- 70934-905
- 11-digit product format
- 709340905
- Labeler code
- 70934
- Product ID
- 70934-905_d5e297d4-b10b-9aa9-e053-2a95a90a6709
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clarithromycin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA065136
- Marketing category
- ANDA
- Marketing start
- 2021-09-28
- Marketing end
- 0000-00-00
- Substance
- CLARITHROMYCIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Macrolide Antimicrobial [EPC], Macrolides [CS], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-905-20 | 70934090520 | 20 TABLET in 1 BOTTLE, PLASTIC (70934-905-20) | 20 tablet | 2022-01-18 | 0000-00-00 | No | No | Current |
| 70934-905-30 | 70934090530 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-905-30) | 30 tablet | 2021-09-28 | 0000-00-00 | No | No | Current |